Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label pharmacokinetic study of isoniazid suspension in children under 6 years with tuberculosis infection
2016-002000-31Phase 2Active
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isoniazid in Tuberculosis (TB), latent tuberculosis infection (LTBI), sponsored by Fundació Sant Joan de Déu. Started Aug 2016; status: active.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on 2016-002000-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002000-31.